Maquet Medical Systems USA has begun a partnership with Biotronik. Maquet, a Getinge Group company, is to distribute Biotronik’s peripheral vascular devise in the USA.
The agreement will see Maquet distribute a number of products used to treat periperhal artery disease (PAD). These products include the Astron iliac self-expanding stent—which was recently granted US Food and Drug Administration (FDA) approval for the treatment of iliac artery disease—the Passeo percutaneous transluminal angioplasty (PTA) balloon family, and the Fortress family of reinforced sheaths. This distribution will start from the first quarter of 2016.
“Because the global prevalence of this disease is increasing, the need for innovative endovascular devices with which to treat patients is growing,” says Raoul Quintero, president of the Americas at Getinge Group. “Partnering with Biotronik allows us to enhance our current product offerings and expand our existing portfolio of vascular grafts and patches…we can now provide PAD patients in the USA, and the vascular surgeons who treat them, with a complete range of technically-advanced, high-quality endovascular devices.”
Marlou Janssen, president of Biotronik, says, “Maquet is a highly-regarded medical device company that has a wealth of experience marketing innovative technology to clinicians. This partnership will ensure that our peripheral vascular product line, including our newly approved Astron iliac stent, will now benefit patients in the United States.”